Structures by: Elgemeie G. H.
Total: 22
3-Ethoxy-5-phenyl-1<i>H</i>-1,2,4-triazole
C10H11N3O
IUCrData (2019) 4, 4 x190378
a=8.0664(4)Å b=10.0476(5)Å c=12.5229(5)Å
α=79.554(4)° β=81.137(4)° γ=70.517(5)°
Ethyl 2-(5-amino-1-benzenesulfonyl-3-oxo-2,3-dihydro-1<i>H</i>-pyrazol-2-yl)acetate
C13H15N3O5S
Acta Crystallographica Section E (2020) 76, 4 481-483
a=9.2139(4)Å b=8.8122(4)Å c=18.3486(7)Å
α=90° β=104.521(4)° γ=90°
4,6-Dimethyl-2-[(2,3,4,6-tetra-<i>O</i>-acetyl-β-<i>D</i>-galactopyranosyl)sulfanyl]pyrimidine
C20H26N2O9S
Acta Crystallographica Section E (2019) 75, 12 1820-1823
a=11.4868(2)Å b=8.6444(2)Å c=11.5561(2)Å
α=90° β=91.3762(16)° γ=90°
2-[(β-Arabinopyranosyl)sulfanyl]-4,6-diphenylpyridine-3-carbonitrile
C23H20N2O4S
Acta Crystallographica Section E (2018) 74, 6 853-856
a=21.8333(2)Å b=21.8333(2)Å c=8.67551(17)Å
α=90° β=90° γ=90°
Potassium [4-amino-5-(benzo[<i>d</i>]thiazol-2-yl)-6-(methylsulfanyl)pyrimidin-2-yl](phenylsulfonyl)azanide dimethylformamide monosolvate hemihydrate
(C18H14N5O2S31),(K1),(C3H7NO),0.5(H2O)
Acta Crystallographica Section E (2019) 75, 3 367-371
a=11.8407(2)Å b=12.6001(4)Å c=18.8671(5)Å
α=90.160(2)° β=102.361(2)° γ=117.933(3)°
1-Amino-2-oxo-2,5,6,7,8,9-hexahydro-1<i>H</i>-cyclohepta[<i>b</i>]pyridine-3-carbonitrile
C11H13N3O
Acta Crystallographica Section E (2016) 72, 9 1239-1241
a=8.5680(4)Å b=10.0475(4)Å c=11.6778(5)Å
α=90.00° β=103.272(4)° γ=90.00°
(<i>E</i>)-2-Amino-4-methylsulfanyl-6-oxo-1-{[(thiophen-2-yl)methylidene]amino}-1,6-dihydropyrimidine-5-carbonitrile
C11H9N5OS2
Acta Crystallographica Section E (2015) 71, 11 1319-1321
a=11.4650(4)Å b=14.7715(4)Å c=7.5924(3)Å
α=90.00° β=96.397(3)° γ=90.00°
4-{[(Cyanoimino)(methylsulfanyl)methyl]amino}-1,5-dimethyl-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazol-3-one
C14H15N5OS
Acta Crystallographica Section E (2015) 71, 1 104-106
a=7.3620(2)Å b=11.9369(4)Å c=16.6755(5)Å
α=90.00° β=100.191(3)° γ=90.00°
<i>N</i>-(2-Amino-5-cyano-4-methylsulfanyl-6-oxo-1,6-dihydropyrimidin-1-yl)-4-bromobenzenesulfonamide dimethylformamide monosolvate
C12H10BrN5O3S2,C3H7NO
Acta Crystallographica Section E (2015) 71, 11 1322-1324
a=9.1107(4)Å b=9.9911(4)Å c=11.6498(6)Å
α=96.482(4)° β=107.802(4)° γ=99.322(4)°
<i>N</i>'-[2-(Benzo[<i>d</i>]thiazol-2-yl)acetyl]-4-methylbenzenesulfonohydrazide
C16H15N3O3S2
Acta Crystallographica Section E (2017) 73, 7 1041-1043
a=8.3436(4)Å b=9.7591(5)Å c=10.8815(6)Å
α=97.905(4)° β=98.142(4)° γ=101.576(4)°
2-Cyano-3,3-bis(ethylthio)-<i>N</i>-<i>o</i>-tolylacrylamide
C15H18N2OS2
Acta Crystallographica Section E (2017) 73, 5 752-754
a=9.4104(4)Å b=12.8350(4)Å c=13.0774(5)Å
α=90.00° β=104.198(4)° γ=90.00°
4,6-Dimethyl-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-\ 2<i>H</i>-pyran-2-yl]sulfanyl}nicotinonitrile
C14H18N2O5S
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 11 1751-1754
a=7.66978(18)Å b=8.72860(13)Å c=23.7524(4)Å
α=90° β=98.7356(16)° γ=90°
<i>N</i>-[6-Amino-5-(benzo[<i>d</i>]thiazol-2-yl)-3-cyano-4-methylsulfanyl-2-oxo-1,2-dihydropyridin-1-yl]-4-methylbenzenesulfonamide dimethylformamide monosolvate
C21H17N5O3S3,C3H7NO
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 12 1820-1822
a=9.9916(5)Å b=11.7805(6)Å c=11.9776(6)Å
α=88.809(4)° β=79.159(4)° γ=67.245(5)°
6-Amino-4-(methylsulfanyl)-2-oxo-1-tolyl-1,2-dihydropyridine-3,5-dicarbonitrile
C15H12N4OS
Acta Crystallographica Section E (2004) 60, 11 o2107-o2109
a=8.5598(6)Å b=9.6111(5)Å c=17.9319(9)Å
α=90.00° β=100.364(4)° γ=90.00°
2-(2,3',4',6'-Tetra-O-acetyl-β-D-glucopyranosylthio)-4-pyridin-4-yl- 6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridine-3-carbonitrile
C30H33N3O9S
Acta Crystallographica Section E (2002) 58, 11 o1244-o1246
a=8.0237(14)Å b=10.2293(14)Å c=38.636(6)Å
α=90.00° β=90.00° γ=90.00°
2-Phenyl-7,8-dihydro-6H-cyclopenta[e]pyrazolo[1,5-a]pyrimidine
C15H13N3
Acta Crystallographica Section E (2002) 58, 11 o1247-o1249
a=7.006(3)Å b=8.702(3)Å c=19.115(4)Å
α=90.00° β=99.36(3)° γ=90.00°
N-(3-Cyano-2-oxo-2,5,6,7,8,9-hexahydro-1H-cyclohepta[b]pyridin-1- yl)-4-methylbenzenesulfonamide
C18H19N3O3S
Acta Crystallographica Section E (2002) 58, 11 o1293-o1295
a=11.7423(16)Å b=11.9050(14)Å c=12.2458(14)Å
α=90.00° β=91.816(12)° γ=90.00°
N-(3-Cyano-2-oxo-5,6,7,8-tetrahydroquinoline-1(2H)-yl)- 4-methylbenzenesulfonamide
C17H17N3O3S
Acta Crystallographica Section E (2002) 58, 11 o1250-o1252
a=11.3275(12)Å b=12.0995(10)Å c=11.8282(10)Å
α=90.00° β=92.377(9)° γ=90.00°
5-Amino-3-anilino-N-(chlorophenyl)-1H-pyrazole-4-carboxamide ethanol solvate
C16H14ClN5O,C2H6O
Acta Crystallographica Section E (2004) 60, 9 o1616-o1618
a=10.6757(10)Å b=7.7798(9)Å c=21.919(2)Å
α=90.00° β=99.140(10)° γ=90.00°
5-Amino-1-(4-methylphenylsulfonyl)-4-pyrazolin-3-one
C10H11N3O3S
Acta Crystallographica Section C (2013) 69, 1 90-92
a=11.9857(2)Å b=7.9094(2)Å c=11.6777(2)Å
α=90.00° β=93.778(2)° γ=90.00°
<i>trans</i>-tetraaquabis{(<i>E</i>)-2-cyano-1- [(ethoxycarbonyl)methylsulfanyl]-2-(1-naphthylaminocarbonyl)ethene-1- thiolato}calcium(II) diethyl ether disolvate
C36H38CaN4O10S4,2(C4H10O)
Acta Crystallographica Section E (2010) 66, 5 m554-m555
a=7.8665(3)Å b=12.4361(5)Å c=13.8045(6)Å
α=103.692(4)° β=99.963(4)° γ=101.609(3)°
(<i>E</i>)-3-Amino-4-(2-phenylhydrazinylidene)-1<i>H</i>- pyrazol-5(4<i>H</i>)-one
C9H9N5O
Acta Crystallographica Section E (2013) 69, 2 o187
a=6.7380(2)Å b=13.4310(4)Å c=10.4563(3)Å
α=90.00° β=103.094(3)° γ=90.00°